After lengthy consideration, a DC federal judge on Monday rejected Merck’s challenge to Medicare drug price ...
Regenxbio's RGX-121 Hunter syndrome gene therapy faces second clinical hold after spinal lumps found in 5 CAMPSIITE trial patients, sending $RGNX shares down 23%.
TwinStrand beats Guardant Health in patent case, wins $245.2M. GSK's hepatitis B drug bepirovirsen (Hibsago) approved in ...
AstraZeneca/Ionis' Wainua trial miss, Cytokinetics' aficamten push into nHCM, and Novartis' pacibekitug in focus after Novo's ...
RFK Jr. seeks to soften CDC vaccine recommendations, shifting flu & meningococcal vaccines to shared decision-making; CDC now ...
Ambros Therapeutics will take the Nasdaq spot of Werewolf Therapeutics, a cancer biotech that has been exploring strategic ...
Genentech builds $750M OR facility; Bavarian Nordic delays Lyme vaccine to 2028; Xspray gets 2nd CRL for Dasynoc over ...
Fresh off a new accelerated approval for its melanoma therapy, Replimune has named Michelle DiNapoli as chief commercial officer.
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
FDA rejects Osteal Therapeutics' Nexchange Kit antibiotic combo for joint-implant infections, citing trial-design flaws and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results